#pavmed
Latest news and interesting information about pavmed.
PAVmed Q1 2026: Restructuring Gains Highlighted
PAVmed Inc. reported Q1 2026 results with restructuring gains and product development progress. Stock up 3.1%.
...
→
EN ▾
Arm, Intel among market cap moversAtisama advances RB042 trial, appoints Bernard Coulie as chairSumitomo Pharma Q4 2025 Beats EPS ForecastsTrump Lifts Sanctions on Chinese FirmsHow long does hantavirus survive at room temperature?Kuleba to Represent Ukraine at WUF13Lavrov's Scandalous Words About FranceJalal Huseynov: My Work Here Is DoneForgent Stock Target Raised to $63 on Record OrdersFiserv Price Target Cut on Execution FearsArm, Intel among market cap moversAtisama advances RB042 trial, appoints Bernard Coulie as chairSumitomo Pharma Q4 2025 Beats EPS ForecastsTrump Lifts Sanctions on Chinese FirmsHow long does hantavirus survive at room temperature?Kuleba to Represent Ukraine at WUF13Lavrov's Scandalous Words About FranceJalal Huseynov: My Work Here Is DoneForgent Stock Target Raised to $63 on Record OrdersFiserv Price Target Cut on Execution Fears